A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency
Abstract Replacement of the in vivo rabies vaccine potency test (NIH test) by in vitro methods had been discussed by several researcher including WHO expert working groups. In this paper, a time-resolved fluoroimmunoassay (TRFIA) for the assay of rabies virus glycoprotein in rabies vaccine was first...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc0a269ebd254638917cd589043832a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:fc0a269ebd254638917cd589043832a0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:fc0a269ebd254638917cd589043832a02021-12-02T11:52:27ZA time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency10.1038/s41598-017-07687-72045-2322https://doaj.org/article/fc0a269ebd254638917cd589043832a02017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07687-7https://doaj.org/toc/2045-2322Abstract Replacement of the in vivo rabies vaccine potency test (NIH test) by in vitro methods had been discussed by several researcher including WHO expert working groups. In this paper, a time-resolved fluoroimmunoassay (TRFIA) for the assay of rabies virus glycoprotein in rabies vaccine was first established to estimate the rabies vaccine potency by using specific monoclonal antibody that only recognized the native, trimeric and immunogenic form of rabies virus glycoprotein. Potency of the rabies virus glycoprotein was assayed with satisfactory performance under optimal conditions, and the method demonstrated satisfactory results when applied in practical samples. The correlation coefficient of potency values obtained from the present TRFIA and ELISA was 0.912, and 0.903 for those from the present TRFIA and NIH test. These preliminary results confirmed that this TRFIA can replace ELISA with higher performance, and could be a promising replacement of the NIH test. Based upon these results, the present TRFIA seemed to be a convenient tool for evaluating rabies vaccine potency and its products at different stages accordingly.Guanfeng LinShaolang ChenHui ZhaoJunyu LiangQiaoting DengRongliang LiangXinxin GuoZhenhua ChenBaihong ChenTiancai LiuYingsong WuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Guanfeng Lin Shaolang Chen Hui Zhao Junyu Liang Qiaoting Deng Rongliang Liang Xinxin Guo Zhenhua Chen Baihong Chen Tiancai Liu Yingsong Wu A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency |
description |
Abstract Replacement of the in vivo rabies vaccine potency test (NIH test) by in vitro methods had been discussed by several researcher including WHO expert working groups. In this paper, a time-resolved fluoroimmunoassay (TRFIA) for the assay of rabies virus glycoprotein in rabies vaccine was first established to estimate the rabies vaccine potency by using specific monoclonal antibody that only recognized the native, trimeric and immunogenic form of rabies virus glycoprotein. Potency of the rabies virus glycoprotein was assayed with satisfactory performance under optimal conditions, and the method demonstrated satisfactory results when applied in practical samples. The correlation coefficient of potency values obtained from the present TRFIA and ELISA was 0.912, and 0.903 for those from the present TRFIA and NIH test. These preliminary results confirmed that this TRFIA can replace ELISA with higher performance, and could be a promising replacement of the NIH test. Based upon these results, the present TRFIA seemed to be a convenient tool for evaluating rabies vaccine potency and its products at different stages accordingly. |
format |
article |
author |
Guanfeng Lin Shaolang Chen Hui Zhao Junyu Liang Qiaoting Deng Rongliang Liang Xinxin Guo Zhenhua Chen Baihong Chen Tiancai Liu Yingsong Wu |
author_facet |
Guanfeng Lin Shaolang Chen Hui Zhao Junyu Liang Qiaoting Deng Rongliang Liang Xinxin Guo Zhenhua Chen Baihong Chen Tiancai Liu Yingsong Wu |
author_sort |
Guanfeng Lin |
title |
A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency |
title_short |
A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency |
title_full |
A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency |
title_fullStr |
A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency |
title_full_unstemmed |
A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency |
title_sort |
time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/fc0a269ebd254638917cd589043832a0 |
work_keys_str_mv |
AT guanfenglin atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT shaolangchen atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT huizhao atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT junyuliang atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT qiaotingdeng atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT rongliangliang atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT xinxinguo atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT zhenhuachen atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT baihongchen atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT tiancailiu atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT yingsongwu atimeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT guanfenglin timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT shaolangchen timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT huizhao timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT junyuliang timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT qiaotingdeng timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT rongliangliang timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT xinxinguo timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT zhenhuachen timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT baihongchen timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT tiancailiu timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency AT yingsongwu timeresolvedfluoroimmunoassaytoassaytherabiesvirusglycoproteinapplicationforestimationofhumanrabiesvaccinepotency |
_version_ |
1718395083181522944 |